Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.25 -0.05 (-0.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Revenue (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) posted Revenue of $44.75 million for Q2 2026, up 259.3% from $12.46 million a year earlier and up 115.7% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Revenue (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Agios Pharmaceuticals was $98.34 million, up 140.6% year-over-year; for FY2025, it was $54.03 million, up 48.0% from FY2024.

  • Annual Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 56.0% (FY2022 to FY2025).
  • In prior years, Agios Pharmaceuticals' Revenue was $36.5 million in FY2024 (+36.1%), $26.82 million in FY2023 (+88.4%) and $14.24 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Revenue since Q1 2020.
  • On a year-over-year basis, Revenue has increased in each of the last 14 quarters, with growth averaging 81.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Revenue ranged from 6.6% (Q1 2025) to 574.2% (Q1 2023).
  • According to Business Quant data, Revenue for the three prior quarters was $20.75 million (Q1 2026), $19.97 million (Q4 2025) and $12.88 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn 44.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.75 Mn
Mar 31, 2026 20.75 Mn
Dec 31, 2025 19.97 Mn
Sep 30, 2025 12.88 Mn
Jun 30, 2025 12.46 Mn
Mar 31, 2025 8.73 Mn
Dec 31, 2024 10.73 Mn
Sep 30, 2024 8.96 Mn
Jun 30, 2024 8.62 Mn
Mar 31, 2024 8.19 Mn
Dec 31, 2023 7.10 Mn
Sep 30, 2023 7.40 Mn
Jun 30, 2023 6.71 Mn
Mar 31, 2023 5.61 Mn
Dec 31, 2022 4.31 Mn
Sep 30, 2022 3.52 Mn
Jun 30, 2022 5.58 Mn
Mar 31, 2022 832,000.00
Dec 31, 2020 44.05 Mn
Sep 30, 2020 34.71 Mn
API Access

Agios Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=AGIO&period=max&api_key=YOUR_API_KEY